|
|
|
- Mary Cross
- 6 years ago
- Views:
Transcription
1 Final Programme EFGCP Children s Medicines Working Party 6th Annual Conference & DIA Paediatric SIAC 4th Forum Current & Future Perspectives for Paediatric Medicines: Visions, Daily Challenges, Ways Forward 28 & 29 September 2010 De Vere Venues Canary Wharf, London, United Kingdom organised by the & European Forum for Good Clinical Practice Drug Information Association Page 1 of 7
2 Conference Rationale The EFGCP Children s Medicines Working Party and DIA Europe are pleased to announce their second joint paediatric conference. Traditional paediatric meetings of both societies in the past and the joint meeting in 2009 have attracted top level speakers from the, Food and Drug Administration (FDA), national authorities, World Health Organization (WHO), academia, pharmaceutical industries and parents & patients organizations. This second joint program will again offer the opportunity for intensive discussion among stakeholders in different topics relevant for paediatric medicines. We will address visions, daily challenges and ways forward in paediatric drug development. On this basis, the conference will also offer excellent networking opportunities for all attendees. The conference will include three parallel breakout sessions on each day for a lively interactive discussion. Furthermore, it will provide participants with the opportunity of asking questions by before the conference and during the morning of day 1, which will be in the afternoon addressed by a speaker panel chaired by Paolo Tomasi, EMA. Conference objectives Update participants how to deal with paediatric regulatory requirements, scientific and operational challenges Exchange experiences with regulatory authorities, academia and industry Discuss visions, daily challenges and potential ways to move forward and further improve processes for paediatric drug development Programme Committee Gesine Bejeuhr Daniel Brasseur Vincent Grek Agnes Gyurasics Karl-Heinz Huemer Angelika Joos Robert "Skip" Nelson Klaus Rose Thomas Severin Ashley Strougo Paolo Tomasi Bernd Zimmerhackl Pediatric Special Interest Area Community (Ped SIAC), DIA & vfa Research- PDCO, & Federal Agency for Medicines and Health Products (FAMHP), Belgium Only For Children Pharmaceuticals (O4CP), France PDCO, & National Institute of Pharmacy, Hungary PDCO, & Austrian Agency for Health and Food Safety (AGES) PharmMed - Austrian Medicines Agency, Austria Merck Sharp & Dohme, Belgium Food and Drug Administration (FDA), USA Children s Medicines Working Party, EFGCP & Granzer Regulatory Consulting & Novartis Pharma, Switzerland Leiden University & Astellas Pharma, The Netherlands University of Innsbruck, Austria Page 2 of 7
3 Faculty Ralph Bax Gesine Bejeuhr Marc Brandsma Daniel Brasseur Melanie Carr Susan Conroy Simon Davies Martine Dehlinger-Kremer Vincent Grek Agnes Gyurasics Ralf Herold Karl-Heinz Huemer Angelika Joos Alastair Kent Dirk Matthys Hannah Millington Robert "Skip" Nelson Gesa Pellier Klaus Rose Agnès Saint-Raymond Juergen Schaefer Ashley Strougo Paolo Tomasi Carlo Tomino Martine Zimmerman Pediatric Special Interest Area Community (Ped SIAC), DIA & vfa Research- Chausson Finance, France PDCO, & Federal Agency for Medicines and Health Products (FAMHP), Belgium Therakind, United Kingdom Teenage Cancer Trust, United Kingdom Paediatric Working Group European CRO Federation (EUCROF) & Omnicare Clinical Research, Germany Only For Children Pharmaceuticals (O4CP), France PDCO, & National Institute of Pharmacy, Hungary PDCO, & Austrian Agency for Health and Food Safety (AGES) PharmMed - Austrian Medicines Agency, Austria Merck Sharp & Dohme, Belgium Genetic Alliance UK, United Kingdom European Academy of Paediatrics (EAP) & University Hospital Ghent, Belgium Teenage Cancer Trust, United Kingdom Food and Drug Administration (FDA), USA European Federation of Pharmaceutical Industries and Associations (EFPIA) & Novartis Pharma, Switzerland Children s Medicines Working Party, European Forum for Good Clinical Practice (EFGCP) & Granzer Regulatory Consulting & European CRO Federation (EUCROF) & Conreso, Germany Leiden University & Astellas Pharma, The Netherlands Italian Medicines Agency (AIFA), Italy Alexion Europe, France Conference Language The language of the Conference was English. Page 3 of 7
4 Conference Venue De Vere Venues Canary Wharf 1st floor 1 Westferry Circus, Canary Wharf London E14 4HA United Kingdom Tel: Fax: canreception@deverevenues.co.uk Website : Page 4 of 7
5 Final Programme Agenda Tuesday, 28 September :00 Registration and Welcome Coffee 08:45 Welcome and Introduction to the Conference Klaus Rose, Children s Medicines Party, EFGCP & Granzer Regulatory Consulting & Services, Germany Gesine Bejeuhr, Pediatric Special Interest Area Community (Ped SIAC), DIA & vfa Research- Plenary Session 1 Visions vs. Daily Operational Challenges Chairperson: Klaus Rose, Children s Medicines Party, EFGCP & Granzer Regulatory Consulting & Services, Germany 09:00 Industry Wish list for Paediatric Drug Development in Europe Gesa Pellier, European Federation of Pharmaceutical Industries and Associations (EFPIA) & Novartis Pharma, Switzerland 09:30 The PDCO Path into the Future Daniel Brasseur, PDCO, & Federal Agency for Medicines and Health Products (FAMHP), Belgium 10:00 Strengths and Weaknesses of Academic Structures in European Paediatric Research Dirk Matthys, European Academy of Paediatrics (EAP) & University Hospital Ghent, Belgium 10:30 Coffee Break 11:00 Three Parallel Breakout Working Groups, Focus on Specific Issues Group 1: Group 2: Group 3: Special challenges in neonates Chair & Rapporteur: Robert "Skip" Nelson, Food and Drug Administration (FDA), USA Introduction: Ralph Bax, Cooperation between academia and industry and the way forward in Paediatric Oncology and Rheumatology Chair: Agnes Gyurasics, PDCO, & National Institute of Pharmacy, Hungary Rapporteur: Ralf Herold, Operational challenges in paediatric clinical trials and how to overcome them Chair & Introduction: Martine Dehlinger-Kremer, Paediatric Working Group European CRO Federation (EUCROF) & Omnicare Clinical Research, Germany Rapporteur: Juergen Schaefer, Paediatric Working Group European CRO Federation (EUCROF) & Conreso, Germany Page 5 of 7
6 12:15 Lunch Plenary Session 2 Getting Paediatric Development Working 13:15 Feedback from Working Groups Chairperson: Angelika Joos, Merck Sharp & Dohme, Belgium Rapporteur Group 1: Robert "Skip" Nelson, Food and Drug Administration (FDA), USA Rapporteur Group 2: Ralf Herold, Rapporteur Group 3: Juergen Schaefer, Paediatric Working Group European CRO Federation (EUCROF) & Conreso, Germany 14:15 Report and tentative answers on questions collected pre-conference Paolo Tomasi, 15:15 Coffee Break 15:45 Panel discussion and general discussion Chairperson: Karl-Heinz Huemer, PDCO, & Austrian Agency for Health and Food Safety (AGES) PharmMed - Austrian Medicines Agency, Austria 16:50 Conclusions Klaus Rose, Children s Medicines Working Party, EFGCP & Granzer Regulatory Consulting & 17:00 End of day 1 19:00 Social Event Keynote Speech on Larger Thinking Alastair Kent, Genetic Alliance UK, United Kingdom Wednesday, 29 September 2010 Plenary Session 3 The Gap between Technically Doable and Politically Feasible Chairperson: Agnes Gyurasics, PDCO, & National Institute of Pharmacy, Hungary 09:00 First World Paediatric Research and Global Efforts: How FDA Tries to Boost Paediatric Research for 3 rd World Diseases? Robert "Skip" Nelson, Federal Drug Agency (FDA), USA 09:45 Funding Paediatric Research: The Italian Example Carlo Tomino, Italian Medicines Agency (AIFA), Italy 10:15 Introduction to Breakout Working Groups Klaus Rose, Children s Medicines Working Party, EFGCP & Granzer Regulatory Consulting & Page 6 of 7
7 10:20 Coffee Break 10:45 Three Parallel Breakout Working Groups, Focus on Specific Issues Group 4: Group 5: Group 6: 12:15 Lunch A toolkit for paediatric research for Small and Medium Enterprises (SMEs) Chair: Melanie Carr, Introduction: Jackie Winslade, Therakind, United Kingdom & Gesine Bejeuhr, Pediatric Special Interest Area Community (Ped SIAC), DIA & vfa Research- Rapporteur: Martine Zimmerman, Alexion Europe, France Funding for paediatric drug development Chair: Vincent Grek, Only For Children Pharmaceuticals (O4CP), France Introduction: Carlo Tomino, Italian Medicines Agency (AIFA), Italy Rapporteur: Marc Brandsma, Chausson Finance, France Media, parents & clinical research: challenges & opportunities Chair & Rapporteur: Simon Davies, Teenage Cancer Trust, United Kingdom Introduction: Hannah Millington, Teenage Cancer Trust, United Kingdom 13:15 Feedback from Working Groups Plenary Session 4 The Way Forward Chairperson: Paolo Tomasi, Rapporteur Group 4: Martine Zimmerman, Alexion Europe, France Rapporteur Group 5: Marc Brandsma, Chausson Finance, France Rapporteur Group 6: Simon Davies, Teenage Cancer Trust, United Kingdom 14:15 Panel discussion and general discussion Chairperson: Agnès Saint-Raymond, 15:40 Conclusions & Farewell Klaus Rose, Children s Medicines Working Party, EFGCP & Granzer Regulatory Consulting & Ashley Strougo, Leiden University & Astellas Pharma, The Netherlands 15:50 End of Meeting Page 7 of 7
Preliminary Programme Version 9 September 2010 EFGCP Children s Medicines Working Party 6th Annual Conference & DIA Paediatric SIAC 4th Forum Current & Future Perspectives for Paediatric Medicines: Visions,
Development of Paediatric Medicines: From Learning to Adapting
Preliminary Programme Joint EFGCP / DIA / EMA Medicines for Children Conference on Development of Paediatric Medicines: From Learning to Adapting 26 & 27 September 2012 De Vere Venues Canary Wharf, London,
Ethical Challenges in Clinical Research at Both Ends of Life
Preliminary Programme, 24 February 2010 v5 EFGCP-EUCROF Joint Workshop on Ethical Challenges in Clinical Research at Both Ends of Life Common Lessons to be learnt from Paediatric & Geriatric Clinical Development
The EFGCP Children s Medicines Working Party 3 rd Annual Conference EU Paediatric Regulation: First European Experiences & Strategic Outlook
The EFGCP Children s Medicines Working Party 3 rd Annual Conference EU Paediatric Regulation: First European Experiences & Strategic Outlook 9 October 2007 - Management Centre Europe, Brussels, Belgium
Final Workshop. Patients Partnering in Clinical Trials. 7 & 8 December 2010 Management Centre Europe Brussels, Belgium
, Final Workshop Patients Partnering in Clinical Trials 7 & 8 December 2010 Management Centre Europe Brussels, Belgium Programme Committee Melissa Hillier Genetic Alliance UK, United Alastair Kent Genetic
Update on public hearing
Update on public hearing PCWP/HCPWP joint meeting Presented by Juan Garcia Burgos on 0 September 017 Head of Public Engagement Department An agency of the European Union A public hearing provides An opportunity
Striving for Professionalism in IITs
EFGCP Workshop on Striving for Professionalism in IITs 26 & 27 February 2014 Courtyard Hotel, Brussels, Belgium Organised by European Forum for Good Clinical Practice In Collaboration with www.efgcp.eu
BDA IMPROVING ONCOLOGY DRUG DEVELOPMENT FOR CHILDREN AND ADOLESCENTS NOVEMBER 2013 WORKSHOP ADVANCE PROGRAMME
BDA WORKSHOP IMPROVING ONCOLOGY DRUG DEVELOPMENT FOR CHILDREN AND ADOLESCENTS 18-19 NOVEMBER 2013 PARIS, FRANCE BIOTHERAPY DEVELOPMENT ASSOCIATION encca European Network for Cancer Research in Children
ACCELERATE. 5 th ACCELERATE Paediatric Oncology Conference SIOP. Brussels, Belgium 2 3 March 2017 CDDF ADVANCE PROGRAMME
ACCELERATE INNOVATION FOR CHILDREN AND ADOLESCENTS WITH CANCER ACCELERATE PLATFORM (CDDF-ITCC-SIOPE MULTI-STAKEHOLDER PLATFORM) 5 th ACCELERATE Paediatric Oncology Conference Brussels, Belgium 2 3 March
ACCELERATE. 6 TH ACCELERATE Paediatric Oncology Conference. Brussels, Belgium 8-9 February 2018 PROGRAMME ACCELERATE MULTISTAKEHOLDER PLATFORM
ACCELERATE INNOVATION FOR CHILDREN AND ADOLESCENTS WITH CANCER ACCELERATE MULTISTAKEHOLDER PLATFORM 6 TH ACCELERATE Paediatric Oncology Conference Brussels, Belgium 8-9 February 2018 PROGRAMME PROGRAMME
EMA/FDA/Health Canada workshop on paediatric pulmonary arterial hypertension (PAH)
12 June 2017 EMA/848554/2016 Rev.1 Human Medicines Research and Development Support Division EMA/FDA/Health Canada workshop on paediatric pulmonary arterial hypertension (PAH) 12-13 June 2017, meeting
JOIN US TO INTEGRATE CLINICAL RESEARCH AND HEALTH CARE
JOIN US TO INTEGRATE CLINICAL RESEARCH AND HEALTH CARE #BridgeTheGap April 4-5, 2018 National Harbor, MD bridgingclinical.com LET'S BUILD A BRIDGE Work with us to bridge the gap between clinical research
European Patients Academy on Therapeutic Innovation
European Patients Academy on Therapeutic Innovation http://www.patientsacademy.eu info@patientsacademy.eu The project is receiving support from the Innovative Medicines Initiative Joint Undertaking under
The 10 year EMA report on the EU regulation with a focus on oncology
The 10 year EMA report on the EU regulation with a focus on oncology 5 th Annual Paediatric Oncology Conference Presented by Koenraad Norga & Franca Ligas on 2 March 2017 An agency of the European Union
HOWDOWEKNOW WHATWORKS?
Expert Conference Federal Centre for Health Education (BZgA) How do we know what works? Programme www.bzga.de/who-conference Date: 22 nd 24 th October 2008 Venue: Berlin, Germany Hotel Aquino Conference
Table Of Content. Page 1/8
Table Of Content 22nd Conference: Changing perceptions, practice and policy... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D04-00 - Programme and book of abstracts (EN)...
SUFFERING, DEATH AND PALLIATIVE CARE
14-17 February 2012 SUFFERING, DEATH AND PALLIATIVE CARE Advanced European Bioethics Course Keynote Speaker: Tony Walter, PhD, professor of death studies Department of Social and Policy Sciences, University
Paediatric strategy forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients
22 August 2018 EMA/242738/2018 Paediatric strategy forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients 5-6 September 2018 30 Churchill
PRELIMINARY PROGRAMME
0 PRELIMINARY PROGRAMME OVERVIEW The aim of the symposium is to provide quality education, based on practical clinical experience, on all aspects of the nurse s role related to the management of thyroid
Cardio Pulmonary Exercise Testing Course 31 st October 2 nd November 2016
31 st October 2 nd November 2016 CPD Credit Applied for Venue Jurys Inn, 245 Broad Street, Birmingham, B1 2HQ Course Overview The aim of this 3 day course is to provide the theoretical background, principles
1 st EULAR-PreS PAED MSUS Course Intermediate
1 st EULAR-PreS PAED MSUS Course Intermediate Madrid, Spain Monday, 10 th June Wednesday, 12 th June 2019 The courses are a combination of lectures and hands-on scanning of models (Basic course) or patients
EULAR-PReS PAEDIATRIC MUSCULOSKELETAL COURSE. Monday 12th Wednesday 14th June 2017 Madrid, Spain
EULAR-PReS PAEDIATRIC MUSCULOSKELETAL COURSE Monday 12th Wednesday 14th June 2017 Madrid, Spain ORGANISATION AND COMMITTEE Scientific organisers Esperanza Naredo Tadej Avcin Jelena Vojinovic Paz Collado
Frequently asked questions
13 February 2017 EMA/527628/2011 Rev. 1 Directorate This document provides answers to the most frequently asked questions received by the European Medicines Agency (EMA).If the answer to your question
EULAR-PReS PAEDIATRIC MUSCULOSKELETAL COURSE. Monday 12th Wednesday 14th June 2017 Madrid, Spain
EULAR-PReS PAEDIATRIC MUSCULOSKELETAL COURSE Monday 12th Wednesday 14th June 2017 Madrid, Spain ORGANISATION AND COMMITTEE Scientific organisers Esperanza Naredo Tadej Avcin Jelena Voijinovic Paz Collado
This meeting has been made possible by an independent grant from Roche.
This meeting has been made possible by an independent grant from Roche. This event has been created in collaboration between the University of Milan and ecancer. MILAN SUMMIT ON PRECISION MEDICINE AGENDA
2008 Public Status Report on the Implementation of the European Risk Management Strategy. Executive Summary
European Medicines Agency London, 17 March 2009 Doc. Ref. EMEA/43556/2009 2008 Status Report on the Implementation of the European Risk Management Strategy Executive Summary The European Risk Management
5 th PVRI Annual Drug Discovery & Development Symposium for Pulmonary Hypertension. The pathway to breakthrough therapies WELCOME TO BETHESDA
Insights from leaders in academia, industry & regulatory... Promising targets ready for clinical development... PVRI Innovative drug discovery for faster approval... Pulmonary vascular diseases... Right
ACCESSIBILITY & IMPACT OF HIGH VALUE MEDICINES
SCIENCE, PATIENTS, POLITICS SYMPOSIUM LONDON SAINT-PANCRAS RENAISSANCE HOTEL ACCESSIBILITY & IMPACT OF HIGH VALUE MEDICINES SCIENCE, PATIENTS, POLITICS ORGANISATION: LA RISK RESEARCH LLP A UNIQUE FORUM
Meeting report, September 2005
European Medicines Agency Post-authorisation Evaluation of Medicines for Human Use London, 24 October 2005 Doc. Ref. EMEA//322553/2005 COMMITTEE ON HERBAL MEDICINAL PRODUCTS () Meeting report, 19-20 September
SOIL HEALTH HUMAN HEALTH CONFERENCE
SPONSOR BRIEF CONFERENCE on CONNECTIONS BETWEEN SOIL HEALTH and HUMAN HEALTH Tuesday, October 16 th Wednesday, October 17 th, 2018 Doubletree by Hilton, Silver Spring, MD Planned for 150 Attendees (Half
SPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 22 nd Global Summit on Pediatrics, Neonatology & Primary Care May 16-17, 2019 Abu Dhabi, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme
European Paediatric Network Legal Basis
Enpr-EMA Joint DIA/EFGCP/EMA Paediatric Forum 26 September 2011 Paolo Rossi Chairman Dept. of Pediatrics Tor Vergata University-Children s Hospital Bambino Gesù, Rome EnprEMA-PDCO Representative An agency
LONDON SHOCK Cardiac Arrest, Resuscitation & Circulatory Support
LONDON SHOCK Cardiac Arrest, Resuscitation & Circulatory Support The Royal Society of Medicine, 1 Wimpole St, Marylebone, London October 2 nd, 2018 Course Director Course Co-Directors Thomas F. Lüscher
PROVISIONAL SCIENTIFIC PROGRAMME AND TIMETABLE
PROVISIONAL SCIENTIFIC PROGRAMME AND TIMETABLE Thursday 17 th October, 2013 09.00- : Executive meetings (only for the Executive and the International Advisory Boards of EURIPA and the Executive of EGPRN),
EURORDIS SUMMER SCHOOL EXPRESS YOURSELF!
EXPERT PATIENTS AND RESEARCHERS EURORDIS SUMMER SCHOOL EXPRESS YOURSELF! CASTELLDEFELS, BARCELONA, SPAIN JUNE 11-15, 2018 A capacity building programme for patient representatives & researchers on medicines
9/20/2011. Impact of EU Paediatric Regulation on drug development and Marketing authorisations Industry experience
Impact of EU Paediatric Regulation on drug development and Marketing authorisations Industry experience Judith Creba Head EU Liaison and Policy, DRA Novartis Pharma AG, Switzerland Disclaimer The views
Fondazione IRCCS, Istituto Nazionale dei Tumori. 2-4 March Milan, Italy
PRACTICE TEACHING COURSE PRELIMINARY PROGRAMME Practice teaching course in head and neck cancer, 2-4 March 2016 - Overview Head and neck cancer treatment requires multidisciplinary cooperation between
OECD WORKSHOP 2000 ON HEALTHY AGEING AND BIOTECHNOLOGY RESEARCH AND POLICY ISSUES
OECD WORKSHOP 2000 ON HEALTHY AGEING AND BIOTECHNOLOGY RESEARCH AND POLICY ISSUES To be held in Tokyo, Japan, on November 13-14, 2000 DRAFT PROGRAMME Date: 13 November - 14 November 2000 Location: Attendance:
SPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES International Conference on n Biomarkers and Cancer Targets December 05-06, 2018 Dubai, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme
MEA Meeting Exhibitor Prospectus
MEA Meeting 2018 11 th International Meeting on Substrate-Integrated Microelectrode Arrays July 4 - July 6, 2018, Exhibitor Prospectus www.nmi.de/meameeting Organized by NMI Natural and Medical Sciences
13 th Congress of the European Hip Society
13 th Congress of the European Hip Society Congress President: Dr. Berend Willem Schreurs, Nijmegen CALL FOR ABSTRACTS 20 22 September 2018 The Hague, The Netherlands www.ehs-congress.org 13 th Congress
The European network for paediatric research. Carlo Giaquinto University of Padova Padova
The European network for paediatric research Carlo Giaquinto University of Padova Padova Types of Paediatric networks (examples) Clinical Trials networks: National networks (MCRN, FinPedMed, CICPed, PaedNet
EUROPEAN MEDICINES AGENCY DECISION. of 22 December 2009
European Medicines Agency Doc. Ref. EMA/816085/2009 P/252/2009 EUROPEAN MEDICINES AGENCY DECISION of 22 December 2009 on the acceptance of a modification of an agreed Paediatric Investigation Plan for
EUROPEAN PHARMACOPOEIA: TACKLING FUTURE CHALLENGES OF THE QUALITY OF MEDICINES TOGETHER
EUROPEAN PHARMACOPOEIA: TACKLING FUTURE CHALLENGES OF THE QUALITY OF MEDICINES TOGETHER International Conference organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM),
Dementia Action Alliance Quarterly Meeting Report. Royal Pharmaceutical Society
Dementia Action Alliance Quarterly Meeting Report Royal Pharmaceutical Society 02.09.2013 Attendees DAA Quarterly Meeting 2013 Agenda Welcome from Chair - Sharon Blackburn, National Care Forum Morning
Introduction. About the Lupus Academy
Content Introduction Past Activities Barcelona 2012 Buenos Aires 2013 Further Development of the Lupus Academy Berlin 2014 Philippines (APLAR) 2014 Educational support programme Budgets 2 Introduction
Diabetes and Endocrinology
CONFERENCES SPONSORSHIP OPPORTUNITIES 2 nd Global Meeting on Diabetes and Endocrinology May 16-17, 2019 Abu Dhabi, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme aims to
8 th Sonography Course Ultrasound Trainers [Teach the Teachers, TTT]
![8 th Sonography Course Ultrasound Trainers [Teach the Teachers, TTT]](/thumbs/96/127818637.jpg "8 th Sonography Course Ultrasound Trainers [Teach the Teachers, TTT]")
8 th Sonography Course Ultrasound Trainers [Teach the Teachers, TTT] Madrid, Spain Saturday, 8 th June Sunday, 9 th June 2019 1 ORGANISATION COMMITTEE Scientific Organisers Esperanza Naredo Ingrid Möller
SPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 5 th World Congress on Epigenetics and Chromosome November 15-16, 2018 Istanbul, Turkey our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme
Masterclass on Clinical Research: How to design a clinical trial
Masterclass on Clinical Research: How to design a clinical trial DAY 1 (Tuesday, 5 March 2013) - Core skills for clinical research 09:30-10:30 Registration and Coffee 10:30 10:35 Welcome Rupert Pearse
32 nd European NEUROLOGY CONGRESS
conferenceseries.com 32 nd European NEUROLOGY CONGRESS July 22-24, 2019 London, UK SCIENTIFIC PROGRAM conferenceseries.com 32 ND EUROPEAN NEUROLOGY CONGRESS Dear colleague, We are glad to announce the
SPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES International Conference on WOMEN S HEALTH, REPRODUCTION AND FERTILITY April 08-09, 2019 Abu Dhabi, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions
ITCC-P4 International Workshop
ITCC P4 GA No. 116064 ITCC-P4 International Workshop IMPROVING PEDIATRIC ONCOLOGY DRUG DEVELOPMENT THROUGH PRECLINICAL RESEARCH September 27 th and 28 th, 2018 // Amsterdam, NL By invitation The event
TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée
Teddy Network of Excellence Annagrazia ALTAVILLA TEDDY Task-force in Europe for Drug Development for the Young Ph.D. Sciences Ethics LL.M. Health Law Associated Senior Lecturer Université de la MéditerranM
8 th Congress of ECCO
European Crohn s and Colitis Organisation Vienna Austria 8 th Congress of ECCO Austria Center Vienna February 14-16, 2013 The major educational event in the field of Inflammatory Bowel Diseases in Europe
https://weiterbildung.zhaw.ch/en/school-of-appliedlinguistics/program/summer-school-barrier-free-communication.html
Summer School Barrier-free Communication Overview Delivery: The Summer School consists of 25 plenary sessions and approximately 15 hours of guided self-study (practical tasks and exercises). In both the
PHOTO. VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe
www.eurordis.org VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe Lucca ( Italy ) March 13-14, 2008 PHOTO www.eurordis.org
European Medicines Agency decision
EMA/662557/2012 European Medicines Agency decision P/0254/2012 of 22 October 2012 on the acceptance of a modification of an agreed paediatric investigation plan for riociguat, (EMEA- 000718-PIP01-09-M02)
Conclusions of the Paediatric Epilepsy Experts Group Meeting, held in London 1 September 2009
29 April 2010 EMA/153272/2010 Human Medicines Development and Evaluation Conclusions of the Paediatric Epilepsy Experts Group Meeting, held in London 1 September 2009 7 Westferry Circus Canary Wharf London
SPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 2 nd Global Physicians and HealthCare Congress June 13-14, 2019 Helsinki, Finland our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme aims
Decision Making Across the Lifespan
40th Annual Meeting EXHIBIT AND SPONSORSHIP October 14-17, 2018 Fairmont The Queen Elizabeth Montreal, QC, Canada Decision Making Across the Lifespan 2018 OCTOBER 14th - 17th SMDM 390 Amwell Road, Suite
SPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 2 nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme aims
Access to innovative oncology medicines in Europe January 2014 Bonn, Germany BDA WORKSHOP BIOTHERAPY DEVELOPMENT ASSOCIATION
BDA WORKSHOP Access to innovative oncology medicines in Europe 16-17 January 2014 Bonn, Germany BIOTHERAPY DEVELOPMENT ASSOCIATION Content Meeting Objectives 2 Organising Committee 2 Who should attend?
SPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 2 nd Head and Neck Conference: The Multidisciplinary Approach December 05-06, 2019 Abu Dhabi, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our
2 WORLD CONGRESS ON CLINICAL PEDIATRICS
CLINICAL CONGRESS 2 WORLD CONGRESS ON CLINICAL nd May 09-10, Amsterdam, Netherlands Invitation Dear Collegues, Conference Series LLC Ltd. is delighted to welcome you to Amsterdam, Netherlands for. The
SPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES International Conference on Oral Health and Dental Medicine November 29-30, 2018 Bali, Indonesia our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our
6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY June 2016 Berlin, Germany. Chairs: A. Eggert, DE B. Morland, UK R.
MASTERCLASS 6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY Held with the support of 11-16 June 2016 Berlin, Germany Chairs: A. Eggert, DE B. Morland, UK R. Riccardi, IT INTRODUCTION ESO and SIOP-Europe
EDQM and European Pharmacopoeia: State-of-the-art Science for Tomorrow s Medicines
EDQM and European Pharmacopoeia: State-of-the-art Science for Tomorrow s Medicines International Conference organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council
SPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES World congress on Polycystic ovarian Syndrome and Fertility October 18-19, 2018 Abu Dhabi, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions PCOS2018
Conference Guidelines
Conference Guidelines The Stress and Anxiety Research Society (STAR) is a multidisciplinary, international organization of researchers who share an interest in problems of stress, coping, and anxiety.
Invitation for the Industry Last update: 11/02/2015 www.comtecmed.com/nesa NESADays2015@Comtecmed.com Dear Colleagues and Friends, The New European Surgical Academy (NESA) is an international, interdisciplinary
PULMONARY HYPERTENSION. by CLINICAL CASES. Archiginnasio Palace
Under the Aegis of European Board for Accreditation in Cardiology PULMONARY HYPERTENSION by CLINICAL CASES An educational event of the University of Bologna Master Degree in Pulmonary Vascular Diseases
CURRENT AND FUTURE CHALLENGES OF INNOVATIVE ONCOLOGY DRUG DEVELOPMENT
CDDF Cancer Drug Development Forum CDDF 8 TH ALPINE CONFERENCE CURRENT AND FUTURE CHALLENGES OF INNOVATIVE ONCOLOGY DRUG DEVELOPMENT INNSBRUCK, AUSTRIA 2-4 MARCH 2015 Workshop objectives The goal of the
WHY SHOULD YOU ATTEND THIS YEAR S FORUM?
The EFQM Forum is an excellent opportunity for you to learn from experts and expand your professional network! The theme for this year s Forum is Achieving Excellence. Throughout the Forum, your current
SPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 2 nd International Conference on Tropical and Infectious Diseases November 21-22, 2019 Bali, Indonesia our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions
Cardiology and Heart Diseases November 5-6, 2018 Amsterdam, Netherlands
C a r d i o l o g y W o r l d 2 0 1 8 28 th World Congress on Cardiology and Heart Diseases November 5-6, 2018 Amsterdam, Netherlands Theme: A Vivid innovations in the field of Cardiology conferenceseries.com
Table Of Content. European Organisation for Rare Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...
Table Of Content European Organisation for Rare Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D04 - Electronic Newsletter (EN)... 7 D01 - Activity Report EURORDIS
European Medicines Agency decision
EMA/761887/2015 European Medicines Agency decision P/0307/2015 of 21 December 2015 on the acceptance of a modification of an agreed paediatric investigation plan for odanacatib (EMEA- 001123-PIP01-11-M03)
International CytoSorb Users Meeting. March 14 th Hotel Marivaux, Brussels
3 rd International CytoSorb Users Meeting March 14 th 2016 - Hotel Marivaux, Brussels 3 rd International CytoSorb Users Meeting Dear CytoSorb user, We are pleased to invite you to our 3rd International
European Medicines Agency decision
EMA/470611/2010 European Medicines Agency decision P/122/2010 of 26 July 2010 on the acceptance of a modification of an agreed paediatric investigation plan for lisdexamfetamine dimesylate, (EMA-000553-PIP01-09-M01)
AIFA UNICRI FDA TRAINING COURSE. on GCP Inspectorates and GCP Inspections
AIFA UNICRI FDA TRAINING COURSE on GCP Inspectorates and GCP Inspections Civil Service Training Centre (CSTC) P.O.Box M49, Cantonments, Accra, Ghana 7-11 July 2014 AGENDA Monday 7 July 2014 8.30 9.00 Registration
WORK PLAN FOR THE EFFICACY WORKING PARTY (EWP) CHAIRPERSON: Barbara van Zwieten-Boot
European Medicines Agency London, 17 December 2009 EMA/CHMP/EWP/248088/2009 Rev. 1 WORK PLAN FOR THE EFFICACY WORKING PARTY (EWP) 2010 CHAIRPERSON: Barbara van Zwieten-Boot 1. MEETINGS SCHEDULED FOR 2010
SPONSORSHIP. Rheumatology, Autoimmunity and Orthopedics. Warsaw, Poland. 9th European Congress on. October 16-17, 2018
9th European Congress on October 16-17, 2018 SPONSORSHIP Rheumatology, Autoimmunity and Orthopedics http://rheumatology.conferenceseries.com/ Invitation Dear Potential Sponsor/Exhibitor, Conference Series
Press Room M0E: Vienna International Centre, Vienna, Austria MONDAY, 11 FEBRUARY 2013 (DAY 1)
Technical Meeting on Topical Issues on Infrastructure Development: Nuclear Power Project Development in Emerging Nuclear Power States 11-14 February 2013 Press Room M0E: Vienna International Centre, Vienna,
Hip Revision. Masterclass. Programme. Chairman: Professor Carsten Perka (DE) Hotel Mövenpick, Berlin, Germany May 2016
Hip Revision Masterclass Programme Chairman: Professor Carsten Perka (DE) Hotel Mövenpick, Berlin, Germany 19-20 May 2016 Page 2 Description This masterclass is a highly focused Healthcare Professional
European Medicines Agency decision
EMA/232938/2014 European Medicines Agency decision P/0102/2014 of 2 May 2014 on the acceptance of a modification of an agreed paediatric investigation plan for corifollitropin alfa (Elonva) (EMEA-000306-PIP01-08-M02)
Building and Managing Databases for the IDCCM NeuroCritical Care in Toronto
Alliance Faculty Day Building and Managing Databases for the IDCCM NeuroCritical Care in Toronto Featured Speakers: Dr. Nicholas Hart (London, UK) Dr. Beverly Orser (Toronto) Wednesday, March 7, 2018 Campbell
September 5 th 7 th, 2018 Innsbruck, Austria
MUSCULOSKELETAL SONOGRAPHY COURSE FOR RHEUMATOLOGISTS - INTERMEDIATE LEVEL - September 5 th 7 th, 2018 Innsbruck, Austria This course is scientifically endorsed by: GENERAL INFORMATION Course opening:
12+ Interactive Sessions. 5+ Workshops. 5+ Keynote Lectures. 10+ Exhibitors. Neurology and Neurosurgery. 50+ Plenary Lectures.
28 th Global Neurologists Annual Meeting on conferenceseries.com Neurology and Neurosurgery November 01-03, 2018 Brussels, Belgium Dear Attendees, Invitation We are glad to announce the 28 th Global Neurologists
Outcome Report on Pilot to involve patients in benefit/risk discussions at CHMP meetings
3 March 2017 EMA/191955/2017 Stakeholders & Communication Division Outcome Report on Pilot to involve patients in benefit/risk discussions at CHMP 1. Background/Rationale A range of mechanisms have been
SPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 6 th International Conference on Medicinal Practices: Herbal, Holistic and Traditional November 18-19, 2019 Helsinki, Finland our DELEGATE is your CLIENT Our Programme
SPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 2 nd World Congress on Nutrition and Obesity Prevention March 21-22, 2019 Dubai, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Nutrition Meet 2019
REGISTER TO ATTEND THIS FREE EVENT. brisbane diamantina health partners
BDHP Brain and Mental Health Conference Translational research in Neuroscience: Bridging the gap between basic science and clinical practice Tuesday 28 August 2018 Bancroft Auditorium QIMR Berghofer Medical
BIOMARKERS AND CANCER TARGETS. 15+ Interactive Sessions. 10+ Keynote Lectures. 40+ Scientific Sessions. 3+ Workshops. 30+ Posters.
15+ Interactive Sessions 10+ Keynote Lectures 40+ Scientific Sessions 3+ Workshops 30+ Posters B2B Meetings CANCER TARGETS 2018 International conference on BIOMARKERS AND CANCER TARGETS July 16-17 Dubai,
Ligament Balancing. Instructional Course. Programme. Chairman: Prof Dr Henrik Schroeder-Boersch (DE) Mühlheim, Düsseldorf, Germany May 2015
Medical Education Ligament Balancing Instructional Course Programme Chairman: Prof Dr Henrik Schroeder-Boersch (DE) Mühlheim, Düsseldorf, Germany 21-22 May 2015 Supporting healthcare professionals for
Class waiver list review
Class waiver list review Background, approach and outcome Consequences for regulatory submissions EMA Industry stakeholder platform on Paediatric medicines Presented by Ralf Herold on 11 May 2015 Paediatric
European Medicines Agency decision
EMA/802543/2012 European Medicines Agency decision P/0293/2012 of 18 December 2012 on the acceptance of a modification of an agreed paediatric investigation plan for prucalopride (Resolor), (EMEA-000459-PIP01-08-M02)